Proteomics International presented its PromarkerD validation clinical study results at the American Diabetes Association’s (ADA) 77th Annual Scientific Sessions, held between 9-13th June, in San Diego, California.
The PromarkerD validation clinical study results were presented in the Late-Breaking abstracts poster section: Abstract #2017-LB-7091
